常染色体显性多囊肾病中近端肾小管分泌的改变
本研究通过靶向质谱定量分析血液和尿液中分泌性溶质,发现eGFR保留的ADPKD患者多种溶质分数排泄已降低;eGFR降低的ADPKD患者较非ADPKD CKD患者分泌排泄更低;ADPKD患者中溶质分数排泄与肾脏体积无关。提示ADPKD中肾小管分泌受损独立于GFR。
要点
- ADPKD患者eGFR正常时即可出现近端肾小管分泌功能下降。
- ADPKD患者肾小管分泌受损程度重于同等eGFR的非ADPKD CKD。
- 肾小管分泌功能与肾脏体积无显著关联。
核心结论
- ADPKD患者无论eGFR保留或降低,均表现出较健康对照和非ADPKD CKD患者更低的肾小管分泌性溶质排泄。
- 结果提示ADPKD中肾小管分泌受损独立于GFR。
研究设计与样本
- 研究纳入31例eGFR保留(平均eGFR 111±11 ml/min/1.73 m2)的ADPKD患者和25例健康对照。
- 另纳入95例eGFR降低(平均eGFR 53±21 ml/min/1.73 m2)的ADPKD患者和92例非ADPKD CKD患者。
- 采用靶向质谱定量血液和尿液中分泌性溶质,用线性回归比较分数排泄。
- 在112例ADPKD患者中分析溶质分数排泄与身高调整总肾脏体积的关联。
主要发现
- 校正人口学、临床特征和肾功能指标后,eGFR保留的ADPKD患者较健康对照:肉桂酰甘氨酸排泄低52%(95%CI 24%–70%),替格酰甘氨酸排泄低53%(95%CI 23%–71%),黄苷排泄低91%(95%CI 83%–95%)。
- eGFR降低的ADPKD患者较eGFR相当的非ADPKD CKD患者:替格酰甘氨酸和黃苷排泄降低,此外二甲基尿酸排泄低37%(95%CI 21%–50%),马尿酸排泄低58%(95%CI 48%–66%),异戊酰甘氨酸排泄低48%(95%CI 37%–56%),吡哆酸排泄低31%(95%CI 16%–42%)。
- ADPKD患者中溶质分数排泄与肾脏体积差异无关。
临床怎么用
- 对于ADPKD患者,即使eGFR正常,也应关注近端肾小管分泌功能可能已受损。
- 评估ADPKD肾功能时,可考虑肾小管分泌标志物作为补充。
局限性
- 样本量有限,ADPKD eGFR保留组仅31例,健康对照25例。
- 横断面设计无法确定因果关系或时序变化。
- 未报告溶质分数排泄与肾脏体积关联的具体数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: In autosomal dominant polycystic kidney disease (ADPKD), the GFR often remains normal despite significant nephron loss. Proximal tubular secretory clearance may be reduced in ADPKD before detectable changes in GFR. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We used targeted mass spectrometry to quantify secretory solutes from blood and urine samples from 31 patients with ADPKD and preserved GFR (mean eGFR =111±11 ml/min per 1.73 m2) and 25 healthy control individuals as well as from 95 patients with ADPKD and reduced GFR (mean eGFR =53±21 ml/min per 1.73 m2) and 92 individuals with non-ADPKD CKD. We used linear regression to compare the fractional excretion of each solute between ADPKD and control groups. Among 112 patients with ADPKD, we used linear regression to determine associations of solute fractional excretion with height-adjusted total kidney volume. RESULTS: After adjusting for demographics, clinical characteristics, and kidney function measures, the fractional excretions of three secretory solutes were lower in patients with ADPKD and preserved GFR compared with healthy individuals: 52% lower cinnamoylglycine excretion (95% confidence interval, 24% to 70%), 53% lower tiglylglycine excretion (95% confidence interval, 23% to 71%), and 91% lower xanthosine excretion (95% confidence interval, 83% to 95%). In addition to lower excretions of tiglylglycine and xanthosine, patients with ADPKD and reduced GFR also demonstrated 37% lower dimethyluric acid excretion (95% confidence interval, 21% to 50%), 58% lower hippurate excretion (95% confidence interval, 48% to 66%), 48% lower isovalerylglycine excretion (95% confidence interval, 37% to 56%), and 31% lower pyridoxic acid excretion (95% confidence interval, 16% to 42%) compared with patients with non-ADPKD CKD and comparable eGFR. Among patients with ADPKD, solute fractional excretions were not associated with differences in kidney volume. CONCLUSIONS: Patients with ADPKD and preserved and reduced GFR demonstrate lower tubular secretory solute excretion compared with healthy controls and patients with non-ADPKD CKD. Our results suggest that tubular secretion is impaired in ADPKD independent of GFR.
引用
- Wang K, Zelnick LR, Chen Y, et al. Alterations of Proximal Tubular Secretion in Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2019. PMID: 31628117. doi:10.2215/CJN.05610519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。